A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

(2020) Shabir A. Madhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

(2020) M. Pamela Griffin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016

(2020) Brian Rha et al.   PEDIATRICS

A proof of concept for structure-based vaccine design targeting RSV in humans

(2019) Michelle C. Crank et al.   SCIENCE

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development

(2019) Seyhan Boyoglu-Barnum et al.   Frontiers in Immunology

Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade

(2019) Sofia S. Aranda et al.   Frontiers in Immunology

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants

(2019) Flor M Muňoz et al.   JOURNAL OF INFECTIOUS DISEASES

Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study

(2019) Jacqueline U. McDonald et al.   VACCINE

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study

(2018) Jacqueline U. McDonald et al.   VACCINE

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

(2017) Judith Falloon et al.   JOURNAL OF INFECTIOUS DISEASES

Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

(2017) Roger Baxter et al.   PEDIATRICS

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

(2017) Anne M. Hause et al.   PLoS One

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

(2015) Gregory M. Glenn et al.   JOURNAL OF INFECTIOUS DISEASES

Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein

(2015) Jason S McLellan   Current Opinion in Virology

Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh

(2014) Helen Y. Chu et al.   JOURNAL OF INFECTIOUS DISEASES

Risk Factors for Hospital Admission with RSV Bronchiolitis in England: A Population-Based Birth Cohort Study

(2014) Joanna Murray et al.   PLoS One

Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants

(2014) Michael L Forbes et al.   Human Vaccines & Immunotherapeutics

RSV Immunoprophylaxis: Does the Benefit Justify the Cost?

(2013) H. C. Meissner et al.   PEDIATRICS

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

(2013) J. S. McLellan et al.   SCIENCE

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

(2013) J. S. McLellan et al.   SCIENCE

Maternal Tetanus Toxoid Vaccination and Neonatal Mortality in Rural North India

(2012) Abhishek Singh et al.   PLoS One

IgG Placental Transfer in Healthy and Pathological Pregnancies

(2011) Patricia Palmeira et al.   Clinical & Developmental Immunology

The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya

(2009) Rachel Ochola et al.   PLoS One

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age

(2009) Joanne M. Langley et al.   VACCINE